mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts.
about
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosisIPF lung fibroblasts have a senescent phenotype.Evidence that a mitochondrial death spiral underlies antagonistic pleiotropy.The Intersection Of Aging Biology and The Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop.microRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells.Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging.Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.Salidroside attenuates hypoxia-induced pulmonary arterial smooth muscle cell proliferation and apoptosis resistance by upregulating autophagy through the AMPK-mTOR-ULK1 pathway.Moderate mammalian target of rapamycin inhibition induces autophagy in HTR8/SVneo cells via O-linked β-N-acetylglucosamine signaling.Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells.Glutaminolysis Promotes Collagen Translation and Stability via α-ketoglutarate Mediated mTOR Activation and Proline Hydroxylation.Extracellular matrix in lung development, homeostasis and disease.Sirtuins and Accelerated Aging in Scleroderma.The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.Rapamycin Protects Against Peritendinous Fibrosis Through Activation of Autophagy.Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells
P2860
Q29248145-17CA25ED-2E2E-448C-BADB-5859F0F4DE47Q38599202-F32EC21B-7337-48FB-81CF-D919EFD529AFQ39129509-317A8D69-2991-42B0-A37F-7943EA720866Q39302712-18236A23-18F2-4ECD-B6F4-5C79E4498DC4Q40969622-3014B7D6-0AC9-4772-A934-01D569E8084BQ44953337-C69B482E-2F2C-4AD0-9421-DF60CF7A972DQ46246621-9C05C7FA-2735-41EC-8161-29B6AA86FB6CQ47160619-D15F47DB-A2F7-4B8A-9790-F5516E5C97D5Q48153810-BA088E55-ACC1-4007-A238-07181EC8D32DQ50027119-54D19AE5-4250-4D0F-B691-73E6DCEBD65AQ50093331-66EA2D0F-5A70-4603-97D5-D04E279FCF5FQ50420061-3E389B29-EB53-4CDF-99B9-5A0DE54D04D8Q51762056-E769ECFA-B5DE-4367-B514-020BF82F060FQ52727884-313FC333-5F81-405F-AD3B-CBDF5E7CD37CQ54942517-A2F70195-44DE-44D2-A07B-9F325C304700Q55332823-06D80FBC-A23A-496A-B3E8-D6E789DC56F0Q57806175-49631F1E-E672-4446-AB53-796C3322E0FE
P2860
mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
mTORC1 activation decreases au ...... resistance in IPF fibroblasts.
@en
mTORC1 activation decreases au ...... resistance in IPF fibroblasts.
@nl
type
label
mTORC1 activation decreases au ...... resistance in IPF fibroblasts.
@en
mTORC1 activation decreases au ...... resistance in IPF fibroblasts.
@nl
prefLabel
mTORC1 activation decreases au ...... resistance in IPF fibroblasts.
@en
mTORC1 activation decreases au ...... resistance in IPF fibroblasts.
@nl
P2093
P2860
P921
P356
P1433
P1476
mTORC1 activation decreases au ...... resistance in IPF fibroblasts
@en
P2093
Ana L Mora
Annie Pardo
Diana Álvarez
Elena A Goncharova
John C Sembrat
Marta Bueno
Mauricio Rojas
Moisés Selman
Remedios Ramirez
P2860
P304
P356
10.1111/ACEL.12514
P50
P577
2016-08-26T00:00:00Z